Virtus ETF Advisers LLC Vor Biopharma Inc. Transaction History

Virtus ETF Advisers LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.89 - $6.44 $48,905 - $80,963	-12,572 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.04 - $12.23 $4,463 - $9,037	-739 Reduced 5.55%	12,572 $76,000
Q4 2021 Feb 14, 2022	BUY	$11.32 - $18.02 $42,766 - $68,079	3,778 Added 39.63%	13,311 $155,000
Q3 2021 Nov 15, 2021	SELL	$12.24 - $20.38 $6,034 - $10,047	-493 Reduced 4.92%	9,533 $149,000
Q2 2021 Aug 10, 2021	BUY	$18.65 - $38.78 $186,984 - $388,808	10,026 New	10,026 $187,000

41.2M

9.3K

100

Ticker VOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,056,300
Market Cap $33.1M
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.